These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 17412363

  • 1. Effects of haloperidol and risperidone on cerebrohemodynamics in drug-naive schizophrenic patients.
    Lee SM, Chou YH, Li MH, Wan FJ, Yen MH.
    J Psychiatr Res; 2008 Mar; 42(4):328-35. PubMed ID: 17412363
    [Abstract] [Full Text] [Related]

  • 2. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 3. Effects of antipsychotics on cognitive performance in drug-naive schizophrenic patients.
    Lee SM, Chou YH, Li MH, Wan FJ, Yen MH.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1101-7. PubMed ID: 17475386
    [Abstract] [Full Text] [Related]

  • 4. [Risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol].
    López Ibor JJ, Ayuso JL, Gutiérrez M, Guimon J, Herraiz ML, Chinchilla A, Ayuso JL, González Pinto A, Eguiluz I, Fernández A.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996 Jun 30; 24(4):165-72. PubMed ID: 8984849
    [Abstract] [Full Text] [Related]

  • 5. Cerebral cortical gray expansion associated with two second-generation antipsychotics.
    Garver DL, Holcomb JA, Christensen JD.
    Biol Psychiatry; 2005 Jul 01; 58(1):62-6. PubMed ID: 15992524
    [Abstract] [Full Text] [Related]

  • 6. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
    Tamrakar SM, Nepal MK, Koirala NR, Sharma VD, Gurung CK, Adhikari SR.
    Kathmandu Univ Med J (KUMJ); 2006 Jul 01; 4(2):152-60. PubMed ID: 18603890
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of the clinical efficacy of risperidone for untreated and treated cases of schizophrenia from various aspects.
    Himei A, Okamura T.
    Psychiatry Clin Neurosci; 2005 Oct 01; 59(5):556-62. PubMed ID: 16194258
    [Abstract] [Full Text] [Related]

  • 9. Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia.
    Rémillard S, Pourcher E, Cohen H.
    J Int Neuropsychol Soc; 2008 Jan 01; 14(1):110-8. PubMed ID: 18078537
    [Abstract] [Full Text] [Related]

  • 10. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA, Morrens M, Sabbe BG.
    Clin Ther; 2008 Sep 01; 30(9):1565-89. PubMed ID: 18840365
    [Abstract] [Full Text] [Related]

  • 11. Antipsychotic drug effects on left prefrontal phospholipid metabolism: a follow-up 31P-2D-CSI study of haloperidol and risperidone in acutely ill chronic schizophrenia patients.
    Smesny S, Langbein K, Rzanny R, Gussew A, Burmeister HP, Reichenbach JR, Sauer H.
    Schizophr Res; 2012 Jul 01; 138(2-3):164-70. PubMed ID: 22516552
    [Abstract] [Full Text] [Related]

  • 12. Effects of haloperidol and risperidone on psychomotor performance relevant to driving ability in schizophrenic patients compared to healthy controls.
    Soyka M, Winter C, Kagerer S, Brunnauer M, Laux G, Möller HJ.
    J Psychiatr Res; 2005 Jan 01; 39(1):101-8. PubMed ID: 15504428
    [Abstract] [Full Text] [Related]

  • 13. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
    Raignoux C, Dusouchet T, Bret P, Queuille E, Biscay ML, Caron J, Bret MC.
    Encephale; 2007 Dec 01; 33(6):973-81. PubMed ID: 18789790
    [Abstract] [Full Text] [Related]

  • 14. Impact of risperidone versus haloperidol on activities of daily living in the treatment of refractory schizophrenia.
    Liberman RP, Gutkind D, Mintz J, Green M, Marshall BD, Robertson MJ, Hayden J.
    Compr Psychiatry; 2002 Dec 01; 43(6):469-73. PubMed ID: 12439835
    [Abstract] [Full Text] [Related]

  • 15. Excitability of the motor cortex in schizophrenia following typical and atypical antipsychotics: two serial case reports.
    Puri BK, Davey NJ, Zaman R.
    Int J Clin Pract; 2003 Nov 01; 57(9):831-3. PubMed ID: 14686575
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Testosterone in first-episode schizophrenia.
    Cesková E, Prikryl R, Kaspárek T.
    Neuro Endocrinol Lett; 2007 Dec 01; 28(6):811-4. PubMed ID: 18063925
    [Abstract] [Full Text] [Related]

  • 18. [Factors connected with the effect of risperidone on psychopathological symptoms and working memory in schizophrenia].
    Borkowska A, Rybakowski J.
    Psychiatr Pol; 2002 Dec 01; 36(6 Suppl):225-33. PubMed ID: 12647443
    [Abstract] [Full Text] [Related]

  • 19. A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.
    Salimi S, Fotouhi A, Ghoreishi A, Derakhshan MK, Khodaie-Ardakani MR, Mohammadi MR, Noorbala AA, Ahmadi-Abhari SA, Hajiazim M, Abbasi SH, Akhondzadeh S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):726-32. PubMed ID: 18096287
    [Abstract] [Full Text] [Related]

  • 20. [From neuroleptics to antipsychotics: the cognitive and emotional impact].
    Blin O, Fakra E, Tardieu S, Micallef J.
    Encephale; 2002 Apr 01; 28 Spec No 2 Pt 2():S16-8. PubMed ID: 12587350
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.